Kakimoto S - Search Results

1

Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.

Hada T, Miyamoto M, Ishibashi H, Kawauchi H, Soyama H, Matsuura H, Sakamoto T, Kakimoto S, Aoyama T, Iwahashi H, Suzuki R, Tsuda H, Takano M. Hada T, et al. Among authors: kakimoto s. In Vivo. 2020 May-Jun;34(3):1341-1346. doi: 10.21873/invivo.11911. In Vivo. 2020. PMID: 32354928 Free PMC article.

2

Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.

Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Tsuda H, Takano M. Hada T, et al. Among authors: kakimoto s. J Ovarian Res. 2021 Feb 14;14(1):33. doi: 10.1186/s13048-021-00783-3. J Ovarian Res. 2021. PMID: 33583413 Free PMC article. Review.

3

Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Suzuki R, Sato K, Tsuda H, Takano M. Hada T, et al. Among authors: kakimoto s. Medicine (Baltimore). 2021 Aug 13;100(32):e26895. doi: 10.1097/MD.0000000000026895. Medicine (Baltimore). 2021. PMID: 34397915 Free PMC article.

4

Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis.

Hada T, Miyamoto M, Ishibashi H, Matsuura H, Kakimoto S, Iwahashi H, Tsuda H, Takano M. Hada T, et al. Among authors: kakimoto s. Diagn Pathol. 2022 Jan 20;17(1):12. doi: 10.1186/s13000-022-01195-7. Diagn Pathol. 2022. PMID: 35057833 Free PMC article.

5

Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine.

Soyama H, Miyamoto M, Matsuura H, Iwahashi H, Kakimoto S, Ishibashi H, Sakamoto T, Hada T, Suminokura J, Takano M. Soyama H, et al. Among authors: kakimoto s. Cancer Chemother Pharmacol. 2020 May;85(5):941-947. doi: 10.1007/s00280-020-04070-8. Epub 2020 Apr 11. Cancer Chemother Pharmacol. 2020. PMID: 32279102

6

Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma.

Kakimoto S, Miyamoto M, Einama T, Matsuura H, Iwahashi H, Ishibashi H, Sakamoto T, Hada T, Takano M. Kakimoto S, et al. Pathol Oncol Res. 2020 Oct;26(4):2299-2306. doi: 10.1007/s12253-020-00823-1. Epub 2020 May 28. Pathol Oncol Res. 2020. PMID: 32468249 Free article.

7

The use of magnetic resonance imaging to predict placenta previa with placenta accreta spectrum.

Ishibashi H, Miyamoto M, Shinmoto H, Soga S, Matsuura H, Kakimoto S, Iwahashi H, Sakamoto T, Hada T, Suzuki R, Takano M. Ishibashi H, et al. Among authors: kakimoto s. Acta Obstet Gynecol Scand. 2020 Dec;99(12):1657-1665. doi: 10.1111/aogs.13937. Epub 2020 Jul 23. Acta Obstet Gynecol Scand. 2020. PMID: 32542670 Free article.

8

Placenta previa may acquire invasive nature by factors associated with epithelial-mesenchymal transition and matrix metalloproteinases.

Soyama H, Miyamoto M, Ishibashi H, Iwahashi H, Matsuura H, Kakimoto S, Suzuki R, Sakamoto T, Hada T, Takano M. Soyama H, et al. Among authors: kakimoto s. J Obstet Gynaecol Res. 2020 Dec;46(12):2526-2533. doi: 10.1111/jog.14485. Epub 2020 Sep 13. J Obstet Gynaecol Res. 2020. PMID: 32924271

9

Applicability of ultrasonography for detection of marginal sinus placenta previa.

Ishibashi H, Miyamoto M, Shinmoto H, Soga S, Iwahashi H, Kakimoto S, Matsuura H, Sakamoto T, Hada T, Suzuki R, Takano M. Ishibashi H, et al. Among authors: kakimoto s. Medicine (Baltimore). 2021 Jan 8;100(1):e24253. doi: 10.1097/MD.0000000000024253. Medicine (Baltimore). 2021. PMID: 33429830 Free PMC article.

10

A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes.

Miyamoto M, Hada T, Ishibashi H, Iwahashi H, Kakimoto S, Suzuki R, Sakamoto T, Matsuura H, Tsuda H, Takano M. Miyamoto M, et al. Among authors: kakimoto s. Anticancer Res. 2021 Feb;41(2):1047-1053. doi: 10.21873/anticanres.14861. Anticancer Res. 2021. PMID: 33517314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters